MAT2A-Mediated S-Adenosylmethionine Level in CD4+ T Cells Regulates HIV-1 Latent Infection

Overview of attention for article published in Frontiers in immunology, September 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users

patent: 1 patent

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MAT2A INHIBITOR AND/OR TSG101 INHIBITOR FOR USE IN ANTIVIRAL THERAPY

Application WO-2023194708-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.